---
title: Reduce falls with treadmill training
nct_id: NCT07058285
phase: NA
status: RECRUITING
sponsor: University of Kiel
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT07058285"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT07058285"
last_fetched: "2026-05-10T14:03:02.816Z"
source: "Parkinson's Pathways (curated)"
---
# Reduce falls with treadmill training

**Goal (in five words):** Reduce falls with treadmill training

**Official Title:** Steps Against the Burden of Parkinson's Disease

**Trial ID:** [NCT07058285](https://clinicaltrials.gov/study/NCT07058285)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** University of Kiel
- **Target Enrollment:** 42 participants
- **Start Date:** 2024-07-25
- **Completion Date:** 2026-03-30
- **Conditions:** Parkinson Disease, Fall
- **Interventions:** Speed-dependent treadmill training (SDTT), SDTT+ anteroposterior perturbations
- **Intervention Types:** OTHER

## Summary For Families

The goal is to reduce falls and improve walking stability and adaptability in people with Parkinson's who have mild to moderate disease and noticeable gait problems. The approach uses speed-dependent treadmill training, where the belt speed responds to your stepping to build steadier, more adaptable gait, and some sessions add brief forward and backward perturbations to practice automatic recovery from trips and slips. This is a rehab therapy that complements medications rather than replacing them. The trial is seeking people diagnosed with Parkinson's by MDS criteria, Hoehn and Yahr stages I to III, with at least mild gait impairment on the MDS-UPDRS, who can give informed consent and walk at least one floor, and who do not have severe depression, major cognitive impairment, implanted deep brain stimulation, or other conditions that make unsupervised exercise unsafe.

## Eligibility

- **Sex:** ALL

### Full Criteria

```
Inclusion criteria

1. Diagnosis of PD according to the MDS Criteria
2. Hoehn and Yahr stages I to III;
3. Movement Disorder Society-sponsored version of the Unified Parkinson Disease Rating Scale (MDS-UPDRS) gait sub-score of 1 or more
4. Signed informed consent to participation

Exclusion criteria

* Any known general health condition likely to interfere with or to pose a contraindication to non-medically supervised physical exercise.
* Moderate or severe depression (BDI-II ≥18)
* Cognitive impairment which may preclude the possibility to provide a fully informed consent to enrolment.
* Linguistic comprehension capacity less than 75% in ordinary conversation
* Severe psychiatric comorbidity which may interfere with compliance to the study protocol
* History of or current status of substance dependency
* Unable to walk less than 1 floor
* Thoracic pain in the last 4 weeks
* Currently enrolled in other interventional studies
* Implanted Deep Brain Stimulation device
```

## Locations (1)

- University of Kiel, Kiel, Germany _(54.3213, 10.1349)_
  - Julius Welzel — (CONTACT) — +49 431 500 23895 — j.welzel@neurologie.uni-kiel.de

## Central Contacts

- Walter Maetzler — (CONTACT) — 0049 431 500-23981 — w.maetzler@neurologie.uni-kiel.de
- Jaap van Dieen — (CONTACT) — j.van.dieen@vu.nl

---

*Canonical: https://parkinsonspathways.com/trial/NCT07058285*  
*HTML version: https://parkinsonspathways.com/trial/NCT07058285*  
*Source data: https://clinicaltrials.gov/study/NCT07058285*